The Goldman Sachs Group, Inc. 13D and 13G filings for Esperion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 2:07 pm Purchase | 2026-06-30 | 13G | ESPERION THERAPEUTICS INC ESPR | GOLDMAN SACHS GROUP INC GS | 17,222,156 6.700% | 17,222,156 (New Position) | Filing |